Cibus - Class A opened lower at $1.15, compared with its previous close of $1.16. In the last trading session, the stock traded between $1.08 and $1.22. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 4 years ago in Cibus - Class A is now worth
$ 4.17
Resulting in a loss of
$ 95.83 (95.83%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 1 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-0.08 (-6.47%)
Day High
$1.22
Day Low
$1.08
Day Open
$1.15
Prev Close
$1.16
Volume
1,57,686
1W Return
-12.07%
1M Return
-26.79%
3M Return
-42.92%
6M Return
-21.38%
1Y Return
-17.80%
Fundamentals
Market Cap ($ Mn)
83
PE Ratio
-
PB Ratio
8.52
PEG Ratio
-
ROE
-215.46%
ROCE
-31.01%
EPS (TTM)
$-0.29
Investment Returns
1 Week
-12.07%
1 Month
-26.79%
3 Months
-42.92%
6 Months
-21.38%
9 Months
-48.09%
Financials
Quarterly
All values in $ Mn
1.0
Mar 25
0.9
Jun 25
0.6
Sep 25
1.1
Dec 25
1.7
Mar 26
1.0
Jun 26
Updates
29Sep
Crystal Crop signs exclusive deal with Cibus for gene-edited mustard traits
Crystal Crop and Cibus signed an exclusive deal for gene-edited mustard traits in India. India imports ~17 million tonnes of edible oil annually despite growing mustard on 8.5 million hectares. Domestic yields average 1,200-1,400 kg/ha vs 1,800-2,000 kg/ha globally. Partnership aligns with National Mission on Edible Oils targeting 70 million tonnes harvest by 2030-31.
Cibus reported Q2 revenue of $1 million, up 11% YoY, driven by Sustainable Ingredients. Net loss narrowed to $22.1 million as R&D and SG&A costs fell nearly $5 million. Cash usage dropped 31% YoY. Rice launch guidance shifted to 2028.
3mo ago
31Jul
Cibus Q2 Results: Company to report earnings on August 13
Cibus, Inc. will report Q2 2026 results on August 13, 2026, followed by a management conference call at 4:30 p.m. ET. A replay will be available until August 27, 2026.
3mo ago
17Jun
EU rules favor Cibus non-transgenic crop improvements
The European Union's new regulatory framework treats non-transgenic crop improvements as conventional breeding, validating Cibus's technology. This allows traits like disease resistance and pod shatter reduction to enter the EU market via a fast lane. Cibus expects the decision to influence global agricultural regulations and accelerate adoption of its gene-editing platform.
4mo ago
9Jun
Cibus appoints Craig Wichner as CEO to accelerate growth
Cibus, Inc. has appointed Craig Wichner as Chief Executive Officer, effective June 08, 2026, succeeding Peter Beetham who remains President and COO. The appointment is part of a succession strategy aimed at accelerating commercialization targets. Wichner, a board member since November 2025, brings financial acumen and experience from Farmland LP. The company focuses on licensing plant traits developed through its Trait Machine process.
